The roles of CyclinE, Jab1 and archipelago in breast cancer cell cycle dysregulation

被引:0
|
作者
Bonner, SE
Morris, DG
Korbonits, M
Laban, CA
McCarthy, K
Al-Mufti, R
机构
[1] St Bartholomews Hosp, Dept Breast Surg, London, England
[2] St Bartholomews Hosp, Dept Endocrinol, London, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:1309 / 1309
页数:1
相关论文
共 50 条
  • [21] Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
    Kleemann, R
    Hausser, A
    Geiger, G
    Mischke, R
    Burger-Kentischer, A
    Flieger, O
    Johannes, FJ
    Roger, T
    Calandra, T
    Kapurniotu, A
    Grell, M
    Finkelmeier, D
    Brunner, H
    Bernhagen, J
    NATURE, 2000, 408 (6809) : 211 - 216
  • [22] Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51
    Liu, Guohong
    Yu, Mingxia
    Wu, Balu
    Guo, Shuang
    Huang, Xin
    Zhou, Fuling
    Claret, Francois X.
    Pan, Yunbao
    CELLULAR SIGNALLING, 2019, 53 : 39 - 48
  • [23] Prognostic significance of JAB1 expression in laryngeal squamous cell carcinomas
    Dong, YY
    Sui, L
    Watanabe, Y
    Yamaguchi, F
    Hatano, N
    Tokuda, M
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 259 - 266
  • [24] Significance of Jab1 Expression in Human Esophageal Squamous Cell Carcinoma
    Wang, Feng
    Wang, Yuchan
    Yu, Xiaowei
    Yang, Dicheng
    Wang, Zheng
    Lu, Chengbao
    Yuan, Zhongxiang
    Xiao, Mingdi
    Shen, Aiguo
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (06) : 520 - 526
  • [25] Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions
    Ivan, D
    Diwan, AH
    Esteva, FJ
    Prieto, VG
    MODERN PATHOLOGY, 2004, 17 (07) : 811 - 818
  • [26] The role and mechanism of JAB1 as a therapeutic target in biliary tract cancer
    Nam, Ah-Rong
    Kang, Kyo Hwa
    Park, Ji Eun
    Bang, Ju-Hee
    Jin, Ling
    Jin, Mei Hua
    Kim, Tae Yong
    Han, Sae-Won
    Song, Sang-Hyun
    Im, Seock-Ah
    Kim, Tae-You
    Oh, Do-Youn
    Bang, Yung-Jue
    CANCER RESEARCH, 2015, 75
  • [27] Cell cycle dysregulation in breast cancer: why the details matter
    Seker, Sinem
    Oropeza, Elena
    Carrel, Sabrina
    Mazumder, Aloran
    Punturi, Nindo
    Lei, Jonathan
    Anurag, Meenakshi
    Lim, Bora
    Bainbridge, Matthew
    Haricharan, Svasti
    CANCER RESEARCH, 2023, 83 (05)
  • [28] Polyethylene Glycosylated Curcumin Conjugate Inhibits Pancreatic Cancer Cell Growth through Inactivation of Jab1
    Li, Jun
    Wang, Yun
    Yang, Chaozhe
    Wang, Pengfei
    Oelschlager, Denise K.
    Zheng, Yong
    Tian, De-An
    Grizzle, William E.
    Buchsbaum, Donald J.
    Wan, Mei
    MOLECULAR PHARMACOLOGY, 2009, 76 (01) : 81 - 90
  • [29] The novel Jab1 inhibitor CSN5i-3 suppresses cell proliferation and induces apoptosis in human breast cancer cells
    Xiao, H.
    Claret, F. X.
    Shen, Q.
    NEOPLASMA, 2019, 66 (03) : 481 - 486
  • [30] Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients
    Hou, Junna
    Liu, Guohong
    Yuan, Yufen
    Wang, Dong
    Jiao, Pengfei
    Xing, Lihua
    Pan, Yunbao
    ONCOTARGET, 2017, 8 (57) : 97504 - 97515